Phosphoinositide 3-kinase in Health and Disease Volume 2 /
From humble beginnings over 25 years ago as a lipid kinase activity associated with certain oncoproteins, PI3K (phosphoinositide 3-kinase) has been catapulted to the forefront of drug development in cancer, immunity and thrombosis, with the first clinical trials of PI3K pathway inhibitors now in pro...
Saved in:
| Corporate Author: | SpringerLink (Online service) |
|---|---|
| Other Authors: | Rommel, Christian. (Editor, http://id.loc.gov/vocabulary/relators/edt), Vanhaesebroeck, Bart. (Editor, http://id.loc.gov/vocabulary/relators/edt), Vogt, Peter K. (Editor, http://id.loc.gov/vocabulary/relators/edt) |
| Format: | Electronic eBook |
| Language: | English |
| Published: |
Berlin, Heidelberg :
Springer Berlin Heidelberg : Imprint: Springer,
2011.
|
| Edition: | 1st ed. 2011. |
| Series: | Current Topics in Microbiology and Immunology,
347 |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/978-3-642-14816-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Phosphoinositide 3-kinase in Health and Disease Volume 1 /
Published: (2011) -
Therapeutic Kinase Inhibitors
Published: (2012) -
NF-kB in Health and Disease
Published: (2011) -
Checkpoint Controls and Cancer Volume 2: Activation and Regulation Protocols /
Published: (2004) -
Protein Kinase C in Cancer Signaling and Therapy
Published: (2010)



